Brochure | March 17, 2020

BioReliance® Gene Therapy Services

Manufacturing and Biosafety Testing for Every Stage of Gene Therapy Development

Gene therapy and gene-modified cell therapy developers like you are providing life-saving therapies to many patients. A critical part of your development process is the establishment of biosafety tests to characterize the cell and virus products going into the manufacturing process, as well as the QC and release testing of clinical batches.

Offering a broad range of services, BioReliance® services support every stage of gene therapy development – from cGMP viral vector process development and manufacturing to a comprehensive set of biosafety tests in accordance with regulatory guidelines. Applying state of the art techniques such as droplet digital PCR as well as established methods to gene therapy testing provides enhanced safety and quality reassurance.

access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Cell & Gene